Skip to main content

Advertisement

SpringerLink
Log in

Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

The role played by endogenous opioids in mediating the reinforcing properties of nicotine is unclear. As with preclinical studies, clinical trials with naloxone, a prototypic opioid receptor antagonist have yielded equivocal findings with regard to its efficacy in reducing cigarette smoking.

Objective

The aim of the present study was to examine the effects of three opioids that exhibit relative selectivity at μ-, κ- and δ-opioid receptors on nicotine self-administration in male hooded Lister rats.

Methods

Graded doses (0.3, 1.0, and 3.0 mg/kg IP) of each opioid agonist or antagonist were tested in different groups of rats repeatedly over three consecutive nicotine intravenous nicotine-self administration (0.03 mg/kg/infusion) sessions. The same treatments were tested in parallel groups of rats trained to respond for food reinforcement.

Results

Naloxone was very effective in attenuating the levels of nicotine self-administered across all doses tested. The selective κ-opioid receptor agonist U50,488, reduced nicotine self-administration in doses of 1 and 3 mg/kg, while the 0.3 mg/kg dose produced a small increase in nicotine intake. Finally, the specific δ-opioid receptor antagonist, naltrindole did not significantly modify nicotine self-administration behaviour. In contrast, all three opioids failed to modify behaviour maintained by food reinforcement.

Conclusions

These findings suggest endogenous opioids are crucial in mediating the reinforcing effects of nicotine and that the μ-opioid receptor subtype may represent a potential target for selectively reducing nicotine-taking behaviour as part of a pharmacological approach to develop smoking cessation aids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Bechara A, van der Kooy D (1985) Opposite motivational effects of endogenous opioids in brain and periphery. Nature 314:533–534

    Article  CAS  PubMed  Google Scholar 

  • Bechara A, Nader K, van der Kooy D (1995) Neurobiology of withdrawal motivation: evidence for two separate aversive effects produced in morphine-naive versus morphine-dependent rats by both naloxone and spontaneous withdrawal. Behav Neurosci 109:91–105

    Article  CAS  PubMed  Google Scholar 

  • Berrendero F, Mendizabal V, Robledo P, Galeote L, Bilkei-Gorzo A, Zimmer A, Maldonado R (2005) Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J Neurosci 25:1103–1112

    Article  CAS  PubMed  Google Scholar 

  • Butschky MF, Bailey D, Henningfield JE, Pickworth WB (1995) Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers. Pharmacol Biochem Behav 50:91–96

    Article  CAS  PubMed  Google Scholar 

  • Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, Hoffman A, Perkins KA, Sved AF (2001) Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70:515–530

    Article  CAS  PubMed  Google Scholar 

  • Chaudhri N, Caggiula AR, Donny EC, Palmatier MI, Liu X, Sved AF (2006) Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl) 184:353–366

    Article  CAS  Google Scholar 

  • Chiamulera C (2005) Cue reactivity in nicotine and tobacco dependence: a “multiple-action” model of nicotine as a primary reinforcement and as a enhancer of the effects of smoking-associated stimuli. Brain Research Reviews 48:74–97

    Article  CAS  PubMed  Google Scholar 

  • Corrigall WA (1999) Nicotine self-administration in animals as a dependence model. Nicotine Tob Res 1:11–20

    Article  CAS  PubMed  Google Scholar 

  • Corrigall WA, Coen KM (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl) 99:473–478

    Article  CAS  Google Scholar 

  • Corrigall WA, Coen KM (1991) Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology (Berl) 104:167–170

    Article  CAS  Google Scholar 

  • Corrigall WA, Herling S, Coen KM (1988) Evidence for opioid mechanisms in the behavioral effects of nicotine. Psychopharmacology (Berl) 96:29–35

    Article  CAS  Google Scholar 

  • Corrigall WA, Franklin KB, Coen KM, Clarke PB (1992) The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 107:285–289

    Article  CAS  Google Scholar 

  • Corrigall WA, Coen KM, Adamson KL, Chow BL, Zhang J (2000) Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology (Berl) 149:107–114

    Article  CAS  Google Scholar 

  • David SP, Lancaster T, Stead LF, Evins AE, Cahill K (2009) Opioid antagonists for smoking cessation. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD003086. doi:10.1002/14651858.CD003086.pub2.

  • DeNoble VJ, Mele PC (2006) Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone. Psychopharmacology (Berl) 184:266–272

    Article  CAS  Google Scholar 

  • Di Chiara G, Imperato A (1988a) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. National Academy of Sciences of the United States of America, pp 5274–5278

  • Di Chiara G, Imperato A (1988b) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067–1080

    PubMed  Google Scholar 

  • Donny EC, Caggiula AR, Knopf S, Brown C (1995) Nicotine self-administration in rats. Psychopharmacology (Berl) 122:390–394

    Article  CAS  Google Scholar 

  • Downs DA, Woods JH (1975) Naloxone as a negative reinforcer in rhesus monkeys: effects of dose, schedule, and narcotic regimen. Pharmacol Rev 27:397–406

    CAS  PubMed  Google Scholar 

  • Downs DA, Woods JH (1976) Morphine, pentazocine and naloxone effects on responding under a multiple schedule of reinforcement in rhesus monkeys and pigeons. J Pharmacol Exp Ther 196:298–306

    CAS  PubMed  Google Scholar 

  • George TP, O’Malley SS (2004) Current pharmacological treatments for nicotine dependence. Trends Pharmacol Sci 25:42–48

    Article  CAS  PubMed  Google Scholar 

  • Giovino GA (2002) Epidemiology of tobacco use in the United States. Oncogene 21:7326–7340

    Article  CAS  PubMed  Google Scholar 

  • Goldberg SR, Henningfield JE (1988) Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection. Pharmacol Biochem Behav 30:227–234

    Article  CAS  PubMed  Google Scholar 

  • Goldberg SR, Hoffmeister F, Schlichting U, Wuttke W (1971) Aversive properties of nalorphine and naloxone in morphine-dependent rhesus monkeys. J Pharmacol Exp Ther 179:268–276

    CAS  PubMed  Google Scholar 

  • Gorelick DA, Rose J, Jarvik ME (1988) Effect of naloxone on cigarette smoking. J Subst Abuse 1:153–159

    Article  PubMed  Google Scholar 

  • Hahn B, Stolerman IP, Shoaib M (2000) Kappa-opioid receptor modulation of nicotine-induced behaviour. Neuropharmacology 39:2848–2855

    Article  CAS  PubMed  Google Scholar 

  • Hand TH, Koob GF, Stinus L, Le Moal M (1988) Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Res 474:364–368

    Article  CAS  PubMed  Google Scholar 

  • Hasenfratz M, Jacober A, Battig K (1993) Smoking-related subjective and physiological changes: pre- to postpuff and pre- to postcigarette. Pharmacol Biochem Behav 46:527–534

    Article  CAS  PubMed  Google Scholar 

  • Heidbreder C, Babovic-Vuksanovic D, Shoaib M, Shippenberg TS (1995) Development of behavioral sensitization to cocaine: Influence of kappa opioid receptor agonists. J Pharmacol Exp Ther 275:150–163

    CAS  PubMed  Google Scholar 

  • Heidbreder C, Shoaib M, Shippenberg TS (1996) Differential role of delta-opioid receptors in the development and expression of behavioral sensitization to cocaine. Eur J Pharmacol 298:207–216

    Article  CAS  PubMed  Google Scholar 

  • Ise Y, Narita M, Nagase H, Suzuki T (2002) Modulation of kappa-opioidergic systems on mecamylamine-precipitated nicotine-withdrawal aversion in rats. Neurosci Lett 323:164–166

    CAS  PubMed  Google Scholar 

  • Karras A, Kane JM (1980) Naloxone reduces cigarette smoking. Life Sci 27:1541–1545

    Article  CAS  PubMed  Google Scholar 

  • King AC, Meyer PJ (2000) Naltrexone alteration of acute smoking response in nicotine-dependent subjects. Pharmacol Biochem Behav 66:563–572

    Article  CAS  PubMed  Google Scholar 

  • Krishnan-Sarin S, Rosen MI, O’Malley SS (1999) Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence. Arch Gen Psychiatry 56:663–668

    Article  CAS  PubMed  Google Scholar 

  • Liu X, Palmatier MI, Caggiula AR, Sved AF, Donny EC, Gharib M, Booth S (2009) Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats. Psychopharmacology (Berl) 202:589–598

    Article  CAS  Google Scholar 

  • Maisonneuve IM, Archer S, Glick SD (1994) U50, 488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci Lett 181:57–60

    Article  CAS  PubMed  Google Scholar 

  • Manzanares J, Lookingland KJ, Moore KE (1991) Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain. J Pharmacol Exp Ther 256:500–505

    CAS  PubMed  Google Scholar 

  • Mucha RF, Millan MJ, Herz A (1985) Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central beta-endorphin. Psychopharmacology (Berl) 86:281–285

    Article  CAS  Google Scholar 

  • Nemeth-Coslett R, Griffiths RR (1986) Naloxone does not affect cigarette smoking. Psychopharmacology (Berl) 89:261–264

    Article  CAS  Google Scholar 

  • Paterson NE, Froestl W, Markou A (2004) The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology (Berl) 172:179–86

    Article  CAS  Google Scholar 

  • Pickworth WB, Lee EM, Abreu ME, Umbricht A, Preston KL (2004) A laboratory study of hydromorphone and cyclazocine on smoking behavior in residential polydrug users. Pharmacol Biochem Behav 77:711–715

    Article  CAS  PubMed  Google Scholar 

  • Portoghese et al (1990) Design of peptidomimetic d opioid receptor antagonists using the message-address concept. J Med Chem 33:1714

    Article  CAS  PubMed  Google Scholar 

  • Rauhut AS, Dwoskin LP, Bardo MT (2005) Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration. Nicotine Tob Res 7:901–907

    Article  CAS  PubMed  Google Scholar 

  • Sannerud CA, Prada J, Goldberg DM, Goldberg SR (1994) The effects of sertraline on nicotine self-administration and food-maintained responding in squirrel monkeys. Eur J Pharmacol 271:461–469

    Article  CAS  PubMed  Google Scholar 

  • Scott DJ, Domino EF, Heitzeg MM, Koeppe RA, Ni L, Guthrie S, Zubieta JK (2007) Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans. Neuropsychopharmacology 32:450–457

    Article  CAS  PubMed  Google Scholar 

  • Shippenberg TS, Bals-Kubik R (1995) Involvement of the mesolimbic dopamine system in mediating the aversive effects of opioid antagonists in the rat. Behav Pharmacol 6:99–106

    Article  CAS  PubMed  Google Scholar 

  • Shoaib M (2008) The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats. Neuropharmacology 54:438–444

    Article  CAS  PubMed  Google Scholar 

  • Shoaib M, Schindler CW, Goldberg SR (1997a) Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology (Berl) 129:35–43

    Article  CAS  Google Scholar 

  • Shoaib M, Thorndike E, Schindler CW, Goldberg SR (1997b) Discriminative stimulus effects of nicotine and chronic tolerance. Pharmacol Biochem Behav 56:167-173

    Article  CAS  PubMed  Google Scholar 

  • Spanagel R, Herz A, Shippenberg TS (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89:2046–2050

    Article  CAS  PubMed  Google Scholar 

  • Stolerman IP, Jarvis MJ (1995) The scientific case that nicotine is addictive. Psychopharmacology (Berl) 117:2–10, discussion 14–20

    Article  CAS  Google Scholar 

  • Stolerman IP, Shoaib M (1991) The neurobiology of tobacco addiction. Trends Pharmacol Sci 12:467–473

    Article  CAS  PubMed  Google Scholar 

  • Suarez-Roca, Maixner (1983) Activation of kappa opioid receptors by U-50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices. J Pharmacol Exp Ther 264:648

    Google Scholar 

  • Sutherland G, Stapleton JA, Russell MA, Feyerabend C (1995) Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology (Berl) 120:418–425

    Article  CAS  Google Scholar 

  • Walters CL, Cleck JN, Kuo YC, Blendy JA (2005) Mu-opioid receptor and CREB activation are required for nicotine reward. Neuron 46:933–943

    Article  CAS  PubMed  Google Scholar 

  • Wong GY, Wolter TD, Croghan GA, Croghan IT, Offord KP, Hurt RD (1999) A randomized trial of naltrexone for smoking cessation. Addiction 94:1227–1237

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The research was funded by Newcastle University. We thank Victoria Wing and Andrew Holt for assisting with some of the behavioural experiments.

Author information

Authors and Affiliations

  1. Psychobiology Research Laboratories, Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK

    Naila Ismayilova & Mohammed Shoaib

Authors
  1. Naila Ismayilova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammed Shoaib
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohammed Shoaib.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ismayilova, N., Shoaib, M. Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats. Psychopharmacology 210, 211–220 (2010). https://doi.org/10.1007/s00213-010-1845-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-010-1845-4

Keywords

Search

Navigation